Statin therapy--Part II: Clinical considerations for cardiovascular disease.

Published

Journal Article (Review)

3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, commonly known as statins, are the medical treatment of choice for hypercholesterolemia. In addition to achieving a therapeutic decrease in serum cholesterol levels, statin therapy appears to promote pleiotropic effects that are independent of changes in serum cholesterol. These cholesterol lowering and pleiotropic effects are beneficial not only for the coronary circulation, but for the myocardium and peripheral arterial system as well. Patients receiving statin therapy must be carefully monitored, however, as statins potentially have harmful side effects and drug interactions. This article is part II of a 2-part review, and it focuses on the clinical aspects of statin therapy in cardiovascular disease.

Full Text

Duke Authors

Cited Authors

  • Sadowitz, B; Seymour, K; Costanza, MJ; Gahtan, V

Published Date

  • August 2010

Published In

Volume / Issue

  • 44 / 6

Start / End Page

  • 421 - 433

PubMed ID

  • 20547576

Pubmed Central ID

  • 20547576

Electronic International Standard Serial Number (EISSN)

  • 1938-9116

International Standard Serial Number (ISSN)

  • 1538-5744

Digital Object Identifier (DOI)

  • 10.1177/1538574410363833

Language

  • eng